Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain
Year of publication: |
2014
|
---|---|
Authors: | Hidalgo-Vega, Álvaro ; Ramos-Goñi, Juan ; Villoro, Renata |
Published in: |
The European Journal of Health Economics. - Springer. - Vol. 15.2014, 9, p. 917-925
|
Publisher: |
Springer |
Subject: | Ranolazine | Costs | Utility | Angina | Pectoris | Placebo | I12 - Health Production | H51 - Government Expenditures and Health | D61 - Allocative Efficiency | Cost–Benefit Analysis |
-
Hidalgo Vega, Alvaro, (2014)
-
Fell, Anja, (2009)
-
Utilities in capital markets : new frontier for operational transformation
Ray, Arin, (2017)
- More ...
-
Ramos-Goñi, Juan, (2013)
-
The social costs of crime in Mexico city and suburban areas
Villoro, Renata, (2004)
-
The social costs of crime in Mexico City and suburban areas
Villoro, Renata, (2004)
- More ...